Sleep quality in university students with premenstrual dysphoric disorder

Khazaie, Saeed; Chehri, Azita

doi:10.1016/j.sleep.2017.11.462

Cited by 8 publications

(10 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cheng et al 27 in a study of 677 university students determined that PMS was associated with poor sleep quality. A study by Khazaie et al 38 identified that 80.5% of students in the premenstrual dysphoric disorder (PMDD) group had low sleep quality, while 56.4% of students in the group without PMDD had low sleep quality. They determined that low sleep quality, daily dysfunction and sleep disorder were among common sleep problems in PMDD students.…”

Section: Discussionmentioning

confidence: 99%

Relationship between premenstrual syndrome and sleep quality among nursing and medical students

Erbi̇l

Yücesoy

2020

Perspect Psychiatric Care

View full text Add to dashboard Cite

Purpose This study was performed to determine relationship between premenstrual syndrome (PMS) and sleep quality among nursing and medical students. Design and Methods This descriptive, cross‐sectional and correlational study was completed with 313 students attending the nursing department and medical faculty. Data were collected using the premenstrual syndrome scale (PMSS) and Pittsburgh sleep quality index (PSQI). Findings The PSQI was positively correlated with PMSS and its subscales scores. Sleep changes were the strongest predictor, followed by depressive thoughts (p < .01), depressive mood, bloating and total PMSS (p < .05) for sleep quality. Practice Implications Training should be organized about PMS for university students to provide information and skills about managing symptoms, and to increase the awareness about this syndrome. Interventional studies should be planned to increase sleep quality in PMS.

show abstract

Section: Discussionmentioning

confidence: 99%

Relationship between premenstrual syndrome and sleep quality among nursing and medical students

Erbi̇l

Yücesoy

2020

Perspect Psychiatric Care

View full text Add to dashboard Cite

show abstract

“…One study indicated that women with premenstrual syndrome (PMS) had poorer sleep quality, a higher perception of unrefreshing sleep, increased total sleep time recorded by polysomnography, a lower saturation of peripheral oxygen, and more subthreshold insomnia [4]. Another study that focused on female university students who experienced PMDD and sleep problems revealed that lower sleep quality, daytime dysfunction, and sleep disturbances were common among such students [5]. Sleep disturbance and decreased melatonin secretion due to hormonal fluctuations during the luteal phase of the menstrual cycle could explain the sleep complaints associated with PMDD [6].…”

Section: Introductionmentioning

confidence: 99%

Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder

Lin

et al. 2021

IJERPH

View full text Add to dashboard Cite

Aim: Premenstrual dysphoric disorder (PMDD) has predictable, cyclic, psychological, and somatic symptoms, such as sleep problems. They result in functional impairment, are aggravated in the late luteal phase of the menstrual cycle, and are resolved by menstruation. The present study evaluated the insomnia, inattention, and fatigue symptoms of PMDD and their fluctuations during the menstrual cycle. Methods: A total of 100 women were diagnosed as having PMDD based on psychiatric interviews and a prospective investigation of three menstrual cycles. A total of 96 individuals without PMDD were recruited as controls. Their symptoms, namely insomnia, inattention, and fatigue as well as functional impairment were assessed by using the premenstrual symptoms screening tool, the Pittsburgh insomnia rating scale, the attention and performance self-assessment scale, and the fatigue-assessment scale during both premenstrual and follicular phases. Results: In both the premenstrual and follicular phases, women with PMDD experienced more severe insomnia, inattentiveness, and fatigue than did women in the control group. A paired t-test demonstrated that women with PMDD had more severe severity insomnia, inattentiveness, and fatigue in the luteal phase than in the follicular phase. A repeated-measures analysis of variance demonstrated that the interaction period of PMDD and a menstrual cycle was significantly associated with insomnia, inattentiveness, and fatigue. A further correlation analysis demonstrated that all three symptoms were positively associated with self-reported functional impairment due to PMDD. Conclusions: Our results demonstrated that women with PMDD experienced an exacerbation of insomnia, memory problems, difficulty maintaining focus, and fatigue in the premenstrual phase. These symptoms are correlated with PMDD symptoms severity and functional impairment, and as such, they should be evaluated, and interventions should be employed in the late luteal phase of women with PMDD.

show abstract

“…Qualitative or quantitative PCR (viral load) was repeated for all patients at the end of treatment and also 12e24 weeks after finishing the treatment to find out the sustained virological response (SVR). Patients were evaluated before the beginning of treatment and 12e24 weeks after finishing their treatment using the Persian translated versions of the Pittsburgh Sleep Quality Index (PSQI) [9], Beck depression inventory questionnaire [10] and SF-36 healthrelated QoL questionnaires [11]. Cirrhosis was confirmed by liver transient elastography (FibroScan).…”

Section: Chronic Hcv-infected Patients Receiving Daas In the Middlementioning

confidence: 99%

Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents

Karimi‐Sari

Hosseini

Nikjoo

et al. 2020

Clinical Microbiology and Infection

View full text Add to dashboard Cite

Objectives: The aim was to investigate the effect of hepatitis C virus (HCV) infection treatment with direct-acting antiviral (DAA) drugs on patients' mood, sleep quality and quality of life (QoL). Methods: Chronic HCV-infected patients receiving DAAs were evaluated prospectively. Patients were evaluated before the beginning of treatment and 12e24 weeks after finishing their treatment duration using the Pittsburgh Sleep Quality Index, Beck depression inventory questionnaire and SF-36 healthrelated QoL questionnaires. Results: A total of 120 patients with a mean age of 41.03 ± 7.68 years were evaluated (68.3% males). The mean follow-up duration was 141.79 ± 27.88 days after finishing the treatment. Significant improvement in the scores of sleep quality (5.13 ± 1.5 vs. 3.43 ± 1.35), mood (12.77 ± 4.02 vs. 9.27 ± 3.14) and QoL (77.49 ± 5.15 vs. 83.95 ± 3.39) post treatment compared with pretreatment were observed (p < 0.05). Changes in patients' sleep and mood were not related to their QoL change (p > 0.05). Discussion: DAAs for the treatment of HCV have a significant effect on improving their sleep, mood and QoL. The changes in sleep quality, mood and QoL of patients were independent and were not affected by each other.

show abstract

Sleep quality in university students with premenstrual dysphoric disorder

Cited by 8 publications

References 28 publications

Relationship between premenstrual syndrome and sleep quality among nursing and medical students

Relationship between premenstrual syndrome and sleep quality among nursing and medical students

Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder

Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents

Contact Info

Product

Resources

About